|
Volumn 335, Issue 7626, 2007, Pages 933-936
|
Systemic lupus erythematosus (British Medical Journal (2007) 335, (933-936) DOI:10.1136/bmj.39358.519491.AD);Systemic lupus erythematosus
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ACETYLSALICYLIC ACID;
ADALIMUMAB;
AZATHIOPRINE;
CHLOROQUINE;
CORTICOSTEROID;
CYCLOPHOSPHAMIDE;
CYCLOSPORIN A;
ETANERCEPT;
HYDROXYCHLOROQUINE;
IMMUNOGLOBULIN;
INFLIXIMAB;
LEFLUNOMIDE;
METHOTREXATE;
MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;
NONSTEROID ANTIINFLAMMATORY AGENT;
PARACETAMOL;
PREDNISOLONE;
RITUXIMAB;
TACROLIMUS;
ADULT;
ARTHRALGIA;
AUTOIMMUNE DISEASE;
CASE REPORT;
CLEFT LIP;
COUNSELING;
FEMALE;
FETOTOXICITY;
HUMAN;
INTRAUTERINE GROWTH RETARDATION;
OLIGOHYDRAMNIOS;
PREGNANCY;
PREGNANCY COMPLICATION;
PREGNANCY OUTCOME;
PREMATURE FETUS MEMBRANE RUPTURE;
PREVALENCE;
PRIORITY JOURNAL;
REVIEW;
RISK ASSESSMENT;
RISK FACTOR;
SIDE EFFECT;
SYSTEMIC LUPUS ERYTHEMATOSUS;
TERATOGENESIS;
|
EID: 35948992257
PISSN: 09598146
EISSN: None
Source Type: Journal
DOI: 10.1136/bmj.39358.519491.AD Document Type: Erratum |
Times cited : (31)
|
References (11)
|